DIAGOMICS has been acquired by ZytoMax, supported by healthcare specialist Archimed investment firm

February 2023 — The owner of DIAGOMICS has sold the company to ZytoMax GmbH.

Founded in 2009 by Gwénola Tanneau and based in Blagnac, France, DIAGOMICS is a specialized retailer of oncology reagents for in-vitro diagnosis for laboratories, hospitals, clinics and research centers in France, Belgium, Luxemburg, Switzerland, Spain, Tunisia and Morocco. With a highly qualified technical service, the highest level of quality control and an optimal quality-price ratio, DIAGOMICS is recognized as an independent reference in the value-added distribution of support reagents to in-vitro diagnosticians.

Structured in 2021 by Archimed, a global investment firm focused on the healthcare industries, ZytoMax brings together the expertise of three companies, ZytoMed, ZytoVision and 42Life Sciences. Based in Berlin, Germany, ZytoMax specializes in the development, manufacture and distribution of diagnostic reagents and system solutions for immunohistology, in-situ hybridization and molecular pathology. The company employs more than 110 people throughout Europe.

Our role in the transaction

Oaklins’ team in France advised DIAGOMICS, a distributor of oncology reagents, on its affiliation with ZytoMax GmbH.

Service

M&A sell-side

Parties

“DIAGOMICS has reached a strategic turning point given its rapid and exponential growth. To strengthen our market position and continue to offer innovative and quality products, DIAGOMICS is joining the ZytoMax group. Our shared values, such as scientific expertise and customer proximity, contributed to this choice.”

Gwénola Tanneau

Founder and CEO, DIAGOMICS

Talk to the deal team

Xavier Auvergnat

Partner

Toulouse, France
Oaklins France

View profile Get in touch

Related deals

Valuation advisory has been provided to a co-investor in VDK

Private Equity | Construction & Engineering Services

Valuation advisory has been provided to a co-investor in VDK

EMK Capital has transferred VDK Groep B.V. from EMK Capital Partners Fund I into the newly established US$1.4 billion single-asset continuation fund, the EMK VDK Partnership Fund, alongside a co-investment from EMK Capital Partners Fund III. The transaction, co-led by LGT Capital Partners and Coller EQT, provides existing investors with the opportunity to retain their exposure to VDK while securing additional capital to support the company’s continued growth and buy-and-build strategy.

Learn more

Be-Cloud has been acquired by PSG Equity

Private Equity | TMT

Be-Cloud has been acquired by PSG Equity

Be-Cloud, backed by B&Capital since 2021, has been acquired by PSG Equity, a leading growth equity firm specializing in software and technology-enabled services. The transaction marks the full exit of B&Capital and the reinvestment of Be-Cloud’s founders, Lenny and Sébastien Vercruysse, alongside PSG Equity.

Learn more

Mattina Holding has sold a 5% stake in Gens Aurea via accelerated bookbuild

Private Equity | Consumer & Retail

Mattina Holding has sold a 5% stake in Gens Aurea via accelerated bookbuild

Mattina Holding S.A. (DVC Partners) has sold a 5% stake in Italian company Gens Aurea S.p.A. through an accelerated bookbuild, raising approximately US$69.96 million.

Learn more